Interrogating genomic diversity of E. coli O157:H7 using DNA tiling arrays

Authors

Scott A. Jackson, U.S. Food and Drug Administration
Mark K. Mammel, U.S. Food and Drug Administration
Isha R. Patel, U.S. Food and Drug Administration
Tammy Mays, U.S. Food and Drug Administration
Thomas J. Albert, NimbleGen Systems Inc.
J. Eugene LeClerc, U.S. Food and Drug Administration
Thomas A. Cebula, U.S. Food and Drug AdministrationFollow

Date of this Version

2007

Citation

Forensic Science International 168 (2007) 183–199; doi:10.1016/j.forsciint.2006.06.079

Abstract

Here, we describe a novel microarray-based approach for investigating the genomic diversity of Escherichia coli O157:H7 in a semi-high throughput manner using a high density, oligonucleotide-based microarray. This microarray, designed to detect polymorphisms at each of 60,000 base-pair (bp) positions within an E. coli genome, is composed of overlapping 29-mer oligonucleotides specific for 60 equally spaced, 1000-bp loci of the E. coli O157:H7 strain EDL933 chromosome. By use of a novel 12-well microarray that permitted the simultaneous investigation of 12 strains, the genomes of 44 individual isolates of E. coli O157:H7 were interrogated. These analyses revealed more than 150 single nucleotide polymorphisms (SNPs) and several deletions and amplifications in the test strains. Pyrosequencing was used to confirm the usefulness of the novel SNPs by determining their allelic frequency among a collection of diverse isolates of E. coli O157:H7. The tiling DNA microarray system would be useful for the tracking and identification of individual strains of E. coli O157:H7 needed for forensic investigations.